{"pub": "marketwatch", "url": "https://marketwatch.com/story/fitbit-stock-gains-after-company-announces-biotech-partnership-2019-10-17", "downloaded_at": "2019-10-17 14:37:54.777519+00:00", "title": "Fitbit stock gains after company announces biotech partnership", "language": "en", "text": "Fitbit Inc. FIT, +0.53% shares are up 3.7% in premarket trading Thursday after the company announced a partnership with the Bristol-Myers Squibb-Pfizer Alliance focused on the diagnosis of atrial fibrillation using Fitbit devices. As atrial fibrillation is a risk factor for stroke, the goal is to use technology to help patients detect this form of irregular heartbeat early on. Bristol-Myers Squibb Co. BMY, +1.74% shares are up 0.4% premarket, while Pfizer Inc. PFE, +1.28% shares are up 0.1%. Fitbit's stock has dropped 15% over the past three months as the S&P 500 SPX, +0.45% has gained 0.2%.", "description": "Fitbit Inc. shares are up 3.7% in premarket trading Thursday after the company announced a partnership with the Bristol-Myers Squibb-Pfizer Alliance focused...", "authors": ["Emily Bary"], "top_image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "published_at": "2019-10-17"}